Cytochrome p450 part 3: drug interactions: essential concepts and considerations.

[1]  Janet K. Williams,et al.  Implications for educating the next generation of nurses on genetics and genomics in the 21st century. , 2011, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[2]  N. Bojanić,et al.  [Drug interactions with grapefruit]. , 2010, Medicinski pregled.

[3]  L. Becquemont,et al.  Pharmacogenomics of adverse drug reactions: practical applications and perspectives. , 2009, Pharmacogenomics.

[4]  W. Aronow,et al.  Updates on Cytochrome P450-Mediated Cardiovascular Drug Interactions , 2009, American journal of therapeutics.

[5]  R. Hazin,et al.  Rhabdomyolysis induced by simvastatin-fluconazole combination. , 2008, Journal of the National Medical Association.

[6]  S. Z. Imam,et al.  Medicinal importance of grapefruit juice and its interaction with various drugs , 2007, Nutrition journal.

[7]  T. Lynch,et al.  The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. , 2007, American family physician.

[8]  I. Zadezensky,et al.  Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided? , 2006, Journal of clinical pharmacology.

[9]  P. Thompson,et al.  Statin-associated myopathy. , 2003, JAMA.

[10]  James P. Wilson,et al.  FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis , 2002, The Annals of pharmacotherapy.

[11]  James P. Wilson,et al.  Rhabdomyolysis and HMG-CoA Reductase Inhibitors , 2001, The Annals of pharmacotherapy.

[12]  T. Ohta,et al.  Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[13]  C. Gregg Drug interactions and anti-infective therapies. , 1999, The American journal of medicine.

[14]  C. Ioannides Cytochromes P450 : role in the metabolism and toxicity of drugs and other xenobiotics , 2008 .

[15]  M. Matsumoto,et al.  Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs , 2005, Drug safety.

[16]  J. Feely,et al.  Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors , 2002, Clinical pharmacokinetics.